Skip to main content

Advertisement

Table 1 Clinical data of patients 1369, 2295 and 3133 from whom the cell lines were derived

From: Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer

  Patients
Clinical parameters 1369 2295 3133 112 1 1946 2
Age at diagnosis 58 59 52 42 75
Tumor type adenocarcinoma adenocarcinoma adenocarcinoma adenocarcinoma adenocarcinoma
Histopathology sub-type serous papillary serous serous papillary endometrioid serous papillary
Tumor grade G3 G3 G3 G3 G3
Disease stage IIIC IIIC IIIC IIIC IIIC
Ascites at surgery yes yes yes yes yes
Surgical debulking sub-optimal sub-optimal sub-optimal sub-optimal sub-optimal
Progression yes yes yes yes yes
Death yes yes yes yes yes
Cause of death disease progression disease progression disease progression disease progression disease progression
Follow up (months) 28 11 22 1 0.3
Treatment paclitaxel/carboplatin cisplatin/topotecan paclitaxel/carboplatin   
  doxorubicin paclitaxel/carboplatin doxorubicin   
  topotecan doxorubicin carboplatin/gemcitabine   
Previous history of cancer breast cancer     
Previous chemotherapy doxorubicine cyclophosphamide docetaxel     
  1. 1[13].
  2. 2[19] Details pertaining to patients 112 and 1946 are also included, from previous published work.